TSE:4151Pharmaceuticals
Kyowa Kirin (TSE:4151) Margin Improvement To 13.5% Reinforces Bullish Earnings Narratives
Kyowa Kirin FY 2025 earnings snapshot
Kyowa Kirin (TSE:4151) has just posted its FY 2025 numbers, with fourth quarter revenue at ¥147,375 million and Basic EPS of ¥65.79, while trailing twelve month revenue stood at ¥496,826 million and Basic EPS at ¥128.07. Over recent periods, the company has seen revenue move from ¥132,760 million in Q4 2024 to ¥147,375 million in Q4 2025, alongside Basic EPS shifting from ¥7.57 to ¥65.79, and on a trailing basis revenue has been in a tight band between...